Effectiveness of multidisciplinary care for Parkinson's disease: A randomized, controlled trial

被引:104
|
作者
van der Marck, Marjolein A. [1 ]
Bloem, Bastiaan R. [2 ]
Borm, George F. [3 ]
Overeem, Sebastiaan [2 ]
Munneke, Marten [1 ,4 ]
Guttman, Mark [5 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, NL-6525 ED Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Evidence Based Practice, Sci Inst Qual Healthcare, NL-6525 ED Nijmegen, Netherlands
[5] Univ Toronto, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
Parkinson disease; randomized; controlled trial; quality of life; multidisciplinary care; patient care team; QUALITY-OF-LIFE; MEMORY CLINICS; REHABILITATION; THERAPY; PEOPLE; HEALTH; INTERVENTIONS; QUESTIONNAIRE; STIMULATION; PROGRESSION;
D O I
10.1002/mds.25194
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multidisciplinary care is considered an optimal model to manage Parkinson's disease (PD), but supporting evidence is limited. We performed a randomized, controlled trial (RCT) to establish whether a multidisciplinary/specialist team offers better outcomes, compared to stand-alone care from a general neurologist. Patients with PD were randomly allocated to an intervention group (care from a movement disorders specialist, PD nurses, and social worker) or a control group (care from general neurologists). Both interventions lasted 8 months. Clinicians and researchers were blinded for group allocation. The primary outcome was the change in quality of life (Parkinson's Disease Questionnaire; PDQ-39) from baseline to 8 months. Other outcomes were the UPDRS, depression (Montgomery-Asberg Depression Scale; MADRS), psychosocial functioning (Scales for Outcomes in Parkinson's disease-Psychosocial; SCOPA-PS), and caregiver strain (Caregiver Strain Index; CSI). Group differences were analyzed using analysis of covariance adjusted for baseline values and presence of response fluctuations. A total of 122 patients were randomized and 100 completed the study (intervention, n = 51; control, n = 49). Compared to controls, the intervention group improved significantly on PDQ-39 (difference, 3.4; 95% confidence interval [CI]: 0.56.2) and UPDRS motor scores (4.1; 95% CI: 0.87.3). UPDRS total score (5.6; 95% CI: 0.910.3), MADRS (3.7; 95% CI: 1.45.9), and SCOPA-PS (2.1; 95% CI: 0.53.7) also improved significantly. This RCT gives credence to a multidisciplinary/specialist team approach. We interpret these positive findings cautiously because of the limitations in study design. Further research is required to assess teams involving additional disciplines and to evaluate cost-effectiveness of integrated approaches. (c) 2012 Movement Disorder Society
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [41] Pilot randomized controlled trial of telemedicine for individuals with Parkinson's disease
    Dorsey, R.
    Deuel, L.
    Appler, A.
    Eason, S.
    George, B.
    Joseph, A.
    Miller, D.
    Polanowicz, J.
    Reminick, J.
    Smith, S.
    Viti, L.
    Voss, T.
    Biglan, K.
    MOVEMENT DISORDERS, 2009, 24 : S261 - S261
  • [42] Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial
    Troche, Michelle S.
    Curtis, James A.
    Sevitz, Jordanna S.
    Dakin, Avery E.
    Perry, Sarah E.
    Borders, James C.
    Grande, Alessandro A.
    Mou, Yuhan
    Vanegas-Arroyave, Nora
    Hegland, Karen W.
    MOVEMENT DISORDERS, 2023, 38 (02) : 201 - 211
  • [43] A Randomized Controlled Trial to Reduce Falls in People With Parkinson's Disease
    Morris, Meg E.
    Menz, Hylton B.
    McGinley, Jennifer L.
    Watts, Jennifer J.
    Huxham, Frances E.
    Murphy, Anna T.
    Danoudis, Mary E.
    Iansek, Robert
    NEUROREHABILITATION AND NEURAL REPAIR, 2015, 29 (08) : 777 - 785
  • [44] Effectiveness of Yijinjing on cognitive and motor functions in patients with Parkinson's disease: study protocol for a randomized controlled trial
    Luo, Kailiang
    Ma, Xinran
    Jin, Xueming
    Liu, Xinhao
    Li, Yujia
    Ma, Shujie
    Hu, Jun
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [45] Innovating Parkinson's Care: A Randomized Controlled Trial of Telemedicine Depression Treatment
    Dobkin, Roseanne D.
    Mann, Sarah L.
    Weintraub, Daniel
    Rodriguez, Kailyn M.
    Miller, Rachael B.
    St. Hill, Lauren
    King, Arlene
    Gara, Michael A.
    Interian, Alejandro
    MOVEMENT DISORDERS, 2021, 36 (11) : 2549 - 2558
  • [46] Effectiveness of pharmacist care for patients with reactive airways disease - A randomized controlled trial
    Weinberger, M
    Murray, MD
    Marrero, DG
    Brewer, N
    Lykens, M
    Harris, LE
    Seshadri, R
    Caffrey, H
    Roesner, JF
    Smith, F
    Newell, AJ
    Collins, JC
    McDonald, CJ
    Tierney, WM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (13): : 1594 - 1602
  • [47] Study protocol of "CHAPS": a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson's Disease to improve the quality of care for individuals with Parkinson's disease
    Connor, Karen
    Cheng, Eric
    Siebens, Hilary C.
    Lee, Martin L.
    Mittman, Brian S.
    Ganz, David A.
    Vickrey, Barbara
    BMC NEUROLOGY, 2015, 15
  • [48] Study protocol of “CHAPS”: a randomized controlled trial protocol of Care Coordination for Health Promotion and Activities in Parkinson’s Disease to improve the quality of care for individuals with Parkinson’s disease
    Karen Connor
    Eric Cheng
    Hilary C. Siebens
    Martin L. Lee
    Brian S. Mittman
    David A. Ganz
    Barbara Vickrey
    BMC Neurology, 15
  • [49] A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson's disease
    Langer, Agnes
    Hasenauer, Sebastian
    Flotz, Anna
    Gassner, Lucia
    Pokan, Rochus
    Dabnichki, Peter
    Wizany, Laurenz
    Gruber, Jakob
    Roth, Dominik
    Zimmel, Sarah
    Treven, Marco
    Schmoeger, Michaela
    Willinger, Ulrike
    Maetzler, Walter
    Zach, Heidemarie
    NPJ PARKINSONS DISEASE, 2021, 7 (01)
  • [50] A randomised controlled trial on effectiveness and feasibility of sport climbing in Parkinson’s disease
    Agnes Langer
    Sebastian Hasenauer
    Anna Flotz
    Lucia Gassner
    Rochus Pokan
    Peter Dabnichki
    Laurenz Wizany
    Jakob Gruber
    Dominik Roth
    Sarah Zimmel
    Marco Treven
    Michaela Schmoeger
    Ulrike Willinger
    Walter Maetzler
    Heidemarie Zach
    npj Parkinson's Disease, 7